Armata Pharmaceuticals (ARMP) Operating Income Growth (1y) (2014 - 2026)
Armata Pharmaceuticals (ARMP) Operating Income Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - | - |
| 10 | Armata Pharmaceuticals | 168.40 Mn | 163.60 Mn | - | -7.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.25% |
| Dec 31, 2025 | -31.16% |
| Sep 30, 2025 | 20.30% |
| Jun 30, 2025 | 42.55% |
| Mar 31, 2025 | 19.92% |
| Dec 31, 2024 | -10.02% |
| Sep 30, 2024 | 5.61% |
| Jun 30, 2024 | -23.73% |
| Mar 31, 2024 | 9.85% |
| Dec 31, 2023 | 7.25% |
| Sep 30, 2023 | -19.87% |
| Jun 30, 2023 | -4.44% |
| Mar 31, 2023 | -29.30% |
| Dec 31, 2022 | -70.77% |
| Sep 30, 2022 | -40.37% |
| Jun 30, 2022 | -48.81% |
| Mar 31, 2022 | -61.45% |
| Dec 31, 2021 | 6.28% |
| Sep 30, 2021 | -9.25% |
| Jun 30, 2021 | -34.99% |